The buzzy injectable drug for type 2 diabetics, Ozempic, has become a household name in 2023 thanks to reports that the medication can be prescribed off-label and used for significant weight loss.
The FDA stopped short, however, of saying that semaglutide, the active ingredient in Ozempic — as well as Wegovy, its counterpart prescribed for weight loss — was the cause of the condition. “Because ...
On September 22, the U.S. Food and Drug Administration added ileus—which can result in intestinal blockage—as a possible adverse event to the Ozempic label. (Photo by Jaap Arriens/NurPhoto via Getty ...
Adhesions from prior abdominal surgeries are the most common cause of SBO. Untreated SBO can lead to serious complications like bowel perforation or tissue death (strangulation). Symptoms of SBO ...